Moderna stock falls after cancer vaccine data leak
Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely watched cancer vaccine developed with Merck. Shares of both drugmakers fell even though the data, released in full later Thursday following the leak, appeared meaningful for patients and positive relative to Wall Street expectations. The personalized vaccine,…